Position in MRNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,974,821
+$4,098,148 QoQ
Shares Held
156,716
+52.3% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#98
of 777 holders
Holding Since
Jun 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. MRNA ranks #75 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in MRNA
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,974,821 | 156,716 | Shares | Sole | 2026-08-14 | |
| 2024-09-30 | $6,876,673 | 102,898 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $29,978,793 | 252,453 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $24,808,100 | 249,453 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $32,352,080 | 313,216 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $31,350,037 | 258,025 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $44,845,052 | 291,998 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $60,355,193 | 336,016 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $39,343,667 | 332,716 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,207,375 | 127,458 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $61,723,514 | 358,316 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $95,475,145 | 375,916 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $125,898,482 | 327,128 | Shares | Sole | 2021-11-15 | |
| 2020-06-30 | $20,868,250 | 325,000 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||